TNF inhibitors in patients with a history of cancer – controversial evidence

medicine Wednesday, 19 June 2024 Vienna – Since the introduction of TNF inhibitors (TNFi) to treat inflammatory diseases such as rheumatoid arthritis (RA), doctors have been concerned that they increase the risk of cancer. The